Class II radical hysterectomy for stage I-IIA cervix cancer: Prognostic factors associated to recurrence and survival in a northeast Brazil experience

Journal of Surgical Oncology

Volumn 104, Issue 3, 2011, Pages 255-259

  Bezerra, Artur Lício Rocha ^a,b   Martins, Mário Rino ^a,b   Bezerra, Simone Maria Muniz Da Silva ^c   Figueiroa, José Natal ^b   Batista, Thales Paulo ^b  

^a Department of Oncological Research   (Brazil)

^b INSTITUTO DE MEDICINA INTEGRAL PROF FERNANDO FIGUEIRA   (Brazil)

^c FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

neoplasm recurrence; postoperative complications; surgical procedure; survival analysis; uterine cervical cancer

Indexed keywords

ADULT; ARTICLE; BRAZIL; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CROSS-SECTIONAL STUDY; FEMALE; FOLLOW UP; HUMAN; HYPOTONIC BLADDER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MORBIDITY; PATIENT SELECTION; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RADICAL HYSTERECTOMY; TUMOR VOLUME; URETHRAL CATHETERIZATION; URINARY TRACT FISTULA; UTERINE CERVIX CANCER; VAGINA; WOUND DEHISCENCE; WOUND INFECTION;

ADENOCARCINOMA; BRAZIL; CARCINOMA, SQUAMOUS CELL; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYSTERECTOMY; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PELVIC NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 80051552598     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21939     Document Type: Article

References (24)

1. Brazilian Ministry of Health. Estimation 2010: Cancer incidence in Brazil. Rio de Janeiro, National Cancer Institute (INCA), 2009. Available on or. Last accessed January 18, 2011.
2. Benedet JL, Bender H, Jones H III, et al.: FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet 2000; 70: 209-262.
3. Piver MS, Rutledge F, Smith JP:, Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol 1974; 44: 265-272.
4. Landoni F, Maneo A, Cormio G, et al.: Class II versus class III radical hysterectomy in stage IB-IIA cervical cancer: A prospective randomized study. Gynecol Oncol 2001; 80: 3-12. (Pubitemid 32062080)
5. Carmo CC, Luiz RR:, Indication of radiotherapy for women with cervical cancer in Rio De Janeiro, Brazil. Int J Gynecol Oncol 2010; 20: 158-163.
6. Covens A, Rosen B, Murphy J, et al.: How important is removal of the parametrium at surgery of carcinoma of the cervix ? Gynecol Oncol 2002; 84: 145-149. (Pubitemid 34056481)
7. Hale RJ, Wilcox FL, Buckley CH, et al.: Prognostic factors in uterine cervical carcinoma: A clinicopathological analysis. Int J Gynecol Cancer 1991; 1: 19-23.
8. Comerci G, Bolger BS, Flammely G, et al.: Prognostic factors in surgically treated stage Ib-IIb carcinoma of the cervix with negative lymph nodes. Int J Gynecol Cancer 1998; 8: 23-26. (Pubitemid 28119953)
9. Ralph G, Winter R, Michelitsch L, et al.: Radicality of parametrial resection and dysfunction of the lower urinary tract after radical hysterectomy. Eur J Gynaecol Oncol 1991; 12: 27-30.
10. Magrina JF, Goodrich MA, Weaver AL, et al.: Modified radical hysterectomy: Morbidity and mortality. Gynecol Oncol 1995; 59: 277-282.
11. Buller RE, Tamir IL, DiSaia PJ, et al.: Early evaluation of the urinary tract following radical hysterectomy: Structure and function relationships. Obstet Gynecol 1991; 78: 840-844.
12. Randall ME, Michael H, LongIII H, et al.: Uterine cervix. In:, Barakat RR, Markman M, Randall ME, editors. Principles and practice of gynecologic oncology. Philadelphia: Lippincott-Raven; 2009. pp. 623-681.
13. Burghardt E, Baltzer J, Tulusan AH, et al.: Results of surgical treatment of 1028 cervical cancers studied with volumetry. Cancer 1992; 70: 648-655.
14. Stehman FB, Bundy BN, DiSaia PJ, et al.: Carcinoma of the cervix treated with radiation therapy. I. A multi-variate analysis of prognostic variables in the Gynecologic Oncology Group. Cancer 1991; 67: 2776-2785.
15. Delgado G, Bundy B, Zaino R, et al.: Prospective surgical-Pathological study of disease-free interval in patients with stage Ib squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study. Gynecol Oncol 1990; 38: 352-357. (Pubitemid 20362555)
16. Raju KS, Kjorstad KE, Abeler V:, Prognostic factors in the treatment of stage Ib adenocarcinoma of the cervix. Int J Gynecol Cancer 1991; 1: 69-74.
17. Ho CM, Chien TY, Huang SH, et al.: Multivariate analysis of the prognostic factors and outcomes in early cervical cancer patients undergoing radical hysterectomy. Gynecol Oncol 2004; 93: 458-464.
18. Jordan LB, Monaghan H:, Pathology of the cervix: Recent developments. Clin Oncol R Coll Radiol 2004; 16: 248-254. (Pubitemid 38696965)
19. Steren A, Nguyen HN, Averette HE, et al.: Radical hysterectomy for stage IB adenocarcinoma of the cervix: The University of Miami experience. Gynecol Oncol 1993; 48: 355-359. (Pubitemid 23090805)
20. Gallup DG, Harper RH, Stock RJ:, Poor prognosis in patients with adenosquamous cell carcinoma of the cervix. Obstet Gynecol 1985; 65: 416-422. (Pubitemid 15134672)
21. Yazigi R, Sandstad J, Munoz AK, et al.: Adenosquamous carcinoma of the cervix: Prognosis in stage IB. Obstet Gynecol 1990; 75: 1012-1015. (Pubitemid 20176775)
22. Mendenhall WM, Thar TL, Bova FJ, et al.: Prognostic and treatment factors affecting pelvic control of stage IB and IIA-B carcinoma of the intact uterine cervix treated with radiation therapy alone. Cancer 1984; 53: 2649-2654. (Pubitemid 14112894)
23. Peters WA III, Liu PY, Barrett RJ II, et al.: Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 2000; 18: 1606-1613. (Pubitemid 30220538)
24. dos Reis R, Frumovitz M, Milam MR, et al.: Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: An outcomes analysis. Gynecol Oncol 2007; 107: 458-463. (Pubitemid 350160856)